OAKLX | VVIAX | OAKLX / VVIAX | |
Total Expense Ratio | 0.99 | 0.05 | 1,980% |
Annual Report Gross Expense Ratio | 0.99 | 0.05 | 1,980% |
Fund Existence | 29 years | 25 years | - |
Gain YTD | 4.579 | 6.198 | 74% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.3B | 189B | 4% |
Annual Yield % from dividends | 0.30 | 2.18 | 14% |
Returns for 1 year | 19.55 | 12.03 | 162% |
Returns for 3 years | 64.94 | 35.17 | 185% |
Returns for 5 years | 132.18 | 80.13 | 165% |
Returns for 10 years | 111.85 | 115.67 | 97% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FFICX | 63.56 | 0.60 | +0.95% |
American Funds Invmt Co of Amer F3 | |||
GMYPX | 17.53 | 0.14 | +0.81% |
Goldman Sachs Large Cap Value P | |||
ETNDX | 19.58 | 0.10 | +0.51% |
Eventide Dividend Growth N | |||
OTTRX | 14.17 | 0.03 | +0.21% |
Otter Creek Long/Short Opportunity Instl | |||
JAGLX | 65.71 | 0.05 | +0.08% |
Janus Henderson Global Life Sciences T |